The use of flow cytometry to assess cell cycle progression and an apoptosis assay using Annexin V-PE and 7-AAD also revealed that the novel ATRA derivatives possess substantial anticancer activity towards human cancer cell lines (MCF-7 and HepG2). Here, ANXA5 is linked to cancer.